An excellent review that summarizes the current evidence-based recommendations for the management of idiopathic crescentic glomerulonephritis. Special attention is also given to the evidence regarding therapeutic options (both induction and maintenance therapies) for diffuse proliferative glomerulonephritis.

Time Required (estimated): 30 minutes
Title: Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: Evidence-based recommendations
Citation: Kidney International 1999, Volume 55, pp. s33-40
Date Created: 1999
Revisions: None Indicated
Disclaimers: None Indicated
Resource Type: Text
Other: Discussed at the East Carolina University’s Nephropathology Conference on April 27, 2010
Recommend to a Colleague/Friend

Was this teaching resource valuable? Scroll down and complete our 6-point Transparent Peer Evaluation.

To access the full-text (only for ECU/ PCMH staff), click here

Transparent Peer Review
Your reviews are anonymous

GD Star Rating

To learn more about our 6-point transparent peer review system, click here

The Management of Idiopathic Crescentic Glomerulonephritis, 6.5 out of 10 based on 1 rating


  • Nephrology On-Demand Plus

    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


  • Kidney Konnection

    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription
More in General Nephrology, Glomerulonephritides (146 of 212 articles)